OTTAWA, Dec. 10, 2013 /CNW/ - Annidis Corporation (TSX Venture: RHA) ("Annidis" or the "Corporation"), creator of the Annidis RHA™, is pleased to announce that it will be
submitting an application to the TSX Venture Exchange ("TSXV") for approval to extend the expiry date of certain issued and
outstanding common share purchase warrants.
In accordance with TSXV Policy 4.1, Annidis Corporation reports that it
will submit an application to the TSXV to extend the term of 3,531,250
warrants which were issued by the Corporation on June 9, 2011 in
connection with the completion of the Corporation's Qualifying
Transaction ("QT"). The warrants are presently exercisable at prices of $0.30 and $0.40
per common share and are set to expire between December 18, 2013 and
November 4, 2014. The Corporation is applying to extend the expiry date
of the warrants to September 30, 2016. All other terms of the warrants,
including the exercise prices, will remain unchanged. The proposed
warrant extensions have been approved by the Corporation's board of
directors, subject to the receipt of TSXV approval.
About Annidis Corporation
Annidis (TSXV: RHA) has developed and is marketing a new imaging
platform technology based on Multi-Spectral Imaging (MSI). This new
technology is opening a new frontier in disease identification and its
management. The Annidis MSI technology allows eye-care professionals to
view non-invasively the deepest areas of the eye aiding eye care
professionals in the early identification and treatment of debilitating
eye diseases. The Company's existing RHA 2020-U Gold, used by eye care
professionals as a broad based tool for detecting early-onset of eye
related diseases such as Dry AMD, has a potential market of over 20,000
clinics in North America. The RHA Platinum MD will further strengthen
the value proposition allowing doctors to visualize choroidal and
retinal vasculature non-invasively. The RHA Platinum MD has global
market potential of more than 100,000 Ophthalmologists.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Annidis Corporation
For further information:
Chief Executive Officer
(519) 858-1582 ext. 239
Virtus Advisory Group Inc.